Fisher Asset Management LLC increased its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 21.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 753,555 shares of the oil and gas company's stock after purchasing an additional 133,375 shares during the period. Fisher Asset Management LLC owned approximately 1.61% of Core Laboratories worth $13,308,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. SG Americas Securities LLC purchased a new position in Core Laboratories during the third quarter worth $525,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Core Laboratories by 31.2% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,787 shares of the oil and gas company's stock worth $259,000 after buying an additional 2,566 shares during the period. Allspring Global Investments Holdings LLC purchased a new position in Core Laboratories during the third quarter worth $31,000. Congress Wealth Management LLC DE boosted its stake in shares of Core Laboratories by 8.7% during the third quarter. Congress Wealth Management LLC DE now owns 153,146 shares of the oil and gas company's stock valued at $3,677,000 after purchasing an additional 12,264 shares during the period. Finally, Congress Asset Management Co. MA boosted its stake in shares of Core Laboratories by 15.9% during the third quarter. Congress Asset Management Co. MA now owns 1,124,863 shares of the oil and gas company's stock valued at $27,008,000 after purchasing an additional 154,608 shares during the period. Institutional investors own 97.81% of the company's stock.
Analyst Ratings Changes
A number of analysts have recently issued reports on the stock. StockNews.com raised shares of Core Laboratories from a "sell" rating to a "hold" rating in a research note on Saturday, January 20th. Stifel Nicolaus boosted their target price on shares of Core Laboratories from $17.00 to $18.00 and gave the company a "hold" rating in a research note on Friday, April 26th. Finally, Bank of America lowered their target price on shares of Core Laboratories from $17.00 to $16.00 and set an "underperform" rating for the company in a research note on Monday, April 15th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $18.75.
Read Our Latest Stock Analysis on Core Laboratories
Core Laboratories Stock Up 0.9 %
NYSE:CLB traded up $0.14 during mid-day trading on Monday, reaching $16.06. The company's stock had a trading volume of 245,240 shares, compared to its average volume of 457,095. Core Laboratories Inc. has a 1 year low of $13.82 and a 1 year high of $27.94. The stock has a fifty day moving average of $16.50 and a 200-day moving average of $17.25. The firm has a market capitalization of $753.21 million, a PE ratio of 18.25, a price-to-earnings-growth ratio of 0.90 and a beta of 2.40. The company has a quick ratio of 1.85, a current ratio of 2.68 and a debt-to-equity ratio of 0.68.
Core Laboratories (NYSE:CLB - Get Free Report) last announced its earnings results on Wednesday, April 24th. The oil and gas company reported $0.13 EPS for the quarter, topping analysts' consensus estimates of $0.11 by $0.02. The business had revenue of $129.64 million during the quarter, compared to the consensus estimate of $124.47 million. Core Laboratories had a net margin of 8.18% and a return on equity of 15.71%. Equities research analysts forecast that Core Laboratories Inc. will post 0.8 earnings per share for the current year.
Core Laboratories Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, May 28th. Shareholders of record on Monday, May 6th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Friday, May 3rd. This represents a $0.04 dividend on an annualized basis and a yield of 0.25%. Core Laboratories's dividend payout ratio is presently 4.55%.
About Core Laboratories
(
Free Report)
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
See Also
Before you consider Core Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Laboratories wasn't on the list.
While Core Laboratories currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
